Corporate News 08-May-12
Orchid Pharma receives USFDA approval for Naratriptan Tabs ANDA
Orchid Chemicals & Pharmaceuticals (Orchid Pharma) has received approval from the USFDA for its ANDA (Abbreviated New Drug Application) for Naratriptan Tablets in the 1 mg and 2.5 mg strengths.
Previous News
Orchid Pharma to conduct board meeting
( Corporate News - 17-May-24 14:12 )
Orchid Pharma to declare Quarterly Result
( Corporate News - 25-May-19 10:31 )
Orchid Chemicals & Pharmaceuticals reports net loss of Rs 80.79 crore in the March 2014 quarter
( Results - Announcements 13-May-14 14:47 )
Orchid Pharma to announce Quarterly Result
( Corporate News - 11-Nov-19 15:57 )
Orchid Pharma gets 90-days extension for CIRP
( Corporate News - 19-Jan-18 19:03 )
Orchid Pharma to hold board meeting
( Corporate News - 04-Feb-23 11:09 )
Orchid Pharma reports consolidated net loss of Rs 6.59 crore in the March 2022 quarter
( Results - Announcements 13-May-22 07:54 )
Orchid Pharma hits 52-week high on receiving EMA nod for Exblifep
( Hot Pursuit - 30-Jan-24 12:55 )
Orchid Chemicals & Pharmaceuticals reports standalone net loss of Rs 148.05 crore in the March 2015 quarter
( Results - Announcements 29-May-15 16:10 )
Orchid Chemicals jumps on USFDA nod for a medicine
( Hot Pursuit - 20-Jun-14 09:16 )
Orchid Chemicals & Pharmaceuticals announces change in nominee director
( Corporate News - 07-Jan-16 13:45 )
Other Stories
Flair Writing Industries appoints CFO
03-Jul-24 11:09
Polycab India allots 12,495 equity shares under ESOS
03-Jul-24 10:21
Magenta Lifecare revises board meeting date
03-Jul-24 10:08
G D Trading & Agencies adjourns board meeting
03-Jul-24 10:06
Shares of Vraj Iron And Steel list today
03-Jul-24 09:39
Rajnish Wellness schedules board meeting
03-Jul-24 09:31
Delta Corp to conduct board meeting
03-Jul-24 09:30
Blue Dart Express to declare Quarterly Result
03-Jul-24 09:30
G D Trading & Agencies to convene board meeting
03-Jul-24 09:30
Chowgule Steamships schedules board meeting
03-Jul-24 09:30
Back
Top
